Vai al contenuto principale della pagina

Novel Biomarkers of Gastrointestinal Cancer



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Shimura Takaya Visualizza persona
Titolo: Novel Biomarkers of Gastrointestinal Cancer Visualizza cluster
Pubblicazione: Basel, : MDPI Books, 2022
Descrizione fisica: 1 electronic resource (248 p.)
Soggetto topico: Medicine
Oncology
Soggetto non controllato: colorectal cancer
advanced adenoma
screening
stool
mRNA
cancer screening
cirrhosis
AFP
machine learning
MALDI-TOF
proteomics
CXCR4
prognosis
overall survival
rectal cancer
neoadjuvant chemoradiation
mouse model
biomarkers
urokinase plasminogen activator (uPA)
urokinase plasminogen activator receptor (uPAR)
plasminogen activator inhibitor type 1 (PAI-1)
circulating tumour cell (CTC)
gastric cancer
oesophageal cancer
serine proteases
tumour microenvironment
serpins
biomarker
chemoresistance
liquid biopsy
microRNA
long non-coding RNA
colorectal neoplasms
cancer screening tests
early detection of cancer
precision medicine
unfolded protein
hepatocellular cancer
GSVA
unfolded protein score
epigenetic regulation genes
somatic mutations
molecular genetic markers
extracellular vesicles
microbiome
16S rRNA amplicon
metagenomics
liver fibrosis
hepatocellular carcinoma
recurrence
SHG/TPEF microscopy
artificial intelligence
advanced gastric cancer
targeted therapy
urinary miRNA
miR-129-1-3p
miR-566
Persona (resp. second.): ShimuraTakaya
Sommario/riassunto: Gastrointestinal (GI) cancer is a major cause of morbidity and mortality in the world. Since early diagnosis and optimal treatment selection are crucial to improving the prognosis of these diseases, the discovery of useful biomarkers has the potential to greatly reduce their burden. Recent technical and mechanical developments have allowed for the detection of tiny differences in various factors modified in physical conditions, which could contribute to the discovery of novel biomarkers for some diseases.In this Special Issue, we aim to focus on novel biomarkers for GI cancers, including esophageal cancer, gastric cancer, colorectal cancer, liver cancer, pancreatic cancer and biliary cancer. In addition, any samples (tissue, blood, urine and feces) are useful as biomarker sources, although body-fluid-based biomarkers are promising as diagnostic biomarkers due to their noninvasiveness. This Special Issue aims to collect novel insights clarifying the current situation and future perspective in this field.
Titolo autorizzato: Novel Biomarkers of Gastrointestinal Cancer  Visualizza cluster
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910595076103321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui